BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma

Roxana S. Dronca, Aaron S. Mansfield, Sean S. Park, Haidong Dong

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'BCL-2-interacting mediator of cell death (Bim) is a novel biomarker for response to anti-PD-1 therapy in patients with advanced melanoma'. Together they form a unique fingerprint.